FBK vs NVG

FBK presents a stark contrast between aggressive growth and deteriorating fundamental health, highlighted by a critical Piotroski F-Score of 2/9. While the company demonstrates impressive YoY revenue and earnings growth (~31%) and a consistent track record of earnings beats, the low health score and bearish insider sentiment are significant red flags. The stock currently trades at a premium to its Graham Number ($46.0) but remains below its growth-based intrinsic value ($72.28). The bullish analyst consensus is heavily countered by poor deterministic health metrics and a bearish technical trend.

NVG exhibits a stable Piotroski F-Score of 6/9, but this is overshadowed by severe valuation discrepancies and unsustainable payout metrics. The current price of $12.63 trades at a significant premium to both the Graham Number ($8.87) and the Intrinsic Value ($6.02). Most critically, a payout ratio of 351.11% indicates that dividends are not being covered by earnings, suggesting a reliance on return of capital or leverage. Combined with a 0/100 technical trend and negative revenue growth, the fund appears overvalued and fundamentally fragile.